Inhibition of Akt/mTOR attenuates age-related changes in mesenchymal stem cells

Research output: Contribution to journalArticlepeer-review

117 Citations (Scopus)


The decline in mesenchymal stem cell (MSC) self-renewal and function with aging contributes to diseases associated with impaired osteogenesis. MSC donor age in prolonged culture also limits the therapeutic potential of these cells for tissue engineering and regenerative medicine. Here we demonstrate an intervention to preserve the immature state MSC and consequently maintain self-renewal and differentiation capacity during in vitro aging. We showed that blocking of PI3K/Akt/mTOR prevents the development of an age related phenotype and maintains MSC morphology of early passage cells with high clonogenic frequency and enhanced proliferative capacity. MSC cultured in the presence of inhibitors of Akt or mTOR also robustly maintain their osteogenic potential, that is otherwise lost during in vitro aging. We further report that these effects may be mediated by induction of expression of pluripotency genes Nanog and Oct-4 and by the reduction in the production of cytoplasmic reactive oxygen species (ROS). Additionally, loss of Akt/mTOR and ROS was accompanied with lower levels of DNA damage. These results provide an insight into mechanisms involved in MSC aging and suggest possible interventions to maintain quiescence and function of MSC prior to in vivo transplantation or as pharmacological agents in diseases associated with loss of MSC function.
Original languageEnglish
Pages (from-to)2256-2266
Number of pages11
JournalStem cells (Dayton, Ohio)
Issue number8
Early online date15 Jul 2014
Publication statusPublished - Aug 2014


Dive into the research topics of 'Inhibition of Akt/mTOR attenuates age-related changes in mesenchymal stem cells'. Together they form a unique fingerprint.

Cite this